… 2218, demonstrating that incorporation of enhanced stabilization chemistry plus technology in VIR-2218 … We also show that VIR-2218 reduces hepatitis B surface antigen levels in a dose…
… We aimed to evaluate the safety and antiviral activity of VIR-2218 … 2218 and up to 48 doses of pegylated interferon-alfa-2a (total 48 weeks); cohort 5 received up to 13 doses of VIR-2218 …
We present a striking new Hubble Space Telescope (HST) observation of the rich cluster Abell 2218 taken with the Wide Field Planetary Camera 2. HST's restored image quality reveals …
… all dose levels, suggesting that VIR-2218 may silence transcripts from both cccDNA and integrated DNA. The antiviral activity of VIR-2218 demonstrated in this study support continued …
… VIR-2218 is designed to silence all HBV transcripts, from … from a Phase 2 trial of VIR-2218 in patients with CHB. Method: … 2 subcutaneous doses of VIR-2218 or placebo on Day 1 (Week …
We report on the detection of dark matter in the cluster Abell 2218 using the weak gravitational distortion of background galaxies. We find a highly significant, coherent detection of the …
… ABSTRACT We present a parametric strong lensing model of the cluster Abell 2218 based … We find that the projected mass distribution of Abell 2218 is bimodal, which is supported by …
We apply a new nonparametric technique to reconstruct, with uncertainties, the projected mass distribution of the inner region of Abell 2218 using combined strong and weak lensing …
We discuss the physical nature of a remarkably faint pair of Lyα-emitting images discovered close to the giant cD galaxy in the lensing cluster Abell 2218 (z = 0.18) during a systematic …
We present deep optical and near-infrared imaging of the rich cluster A 2218 at z = 0.17. Our optical imaging comes from new multicolour Hubble Space Telescope WFPC2 …